SANN.SW
Santhera Pharmaceuticals Holding AG
Price:  
9.25 
CHF
Volume:  
26,474.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SANN.SW WACC - Weighted Average Cost of Capital

The WACC of Santhera Pharmaceuticals Holding AG (SANN.SW) is 6.0%.

The Cost of Equity of Santhera Pharmaceuticals Holding AG (SANN.SW) is 6.50%.
The Cost of Debt of Santhera Pharmaceuticals Holding AG (SANN.SW) is 5.10%.

Range Selected
Cost of equity 4.50% - 8.50% 6.50%
Tax rate 0.50% - 1.00% 0.75%
Cost of debt 4.00% - 6.20% 5.10%
WACC 4.3% - 7.7% 6.0%
WACC

SANN.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.68 1.08
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.50% 8.50%
Tax rate 0.50% 1.00%
Debt/Equity ratio 0.49 0.49
Cost of debt 4.00% 6.20%
After-tax WACC 4.3% 7.7%
Selected WACC 6.0%